Astellas Pharma US Inc.: Drug Recall
Recall #D-0210-2025 · 12/23/2024
Class I: Dangerous
Recall Details
- Recall Number
- D-0210-2025
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Astellas Pharma US Inc.
- Status
- Ongoing
- Date Initiated
- 12/23/2024
- Location
- Northbrook, IL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,500 30-count bottles
Reason for Recall
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Product Description
Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.
Distribution Pattern
Nationwide in the USA
Other Recalls by Astellas Pharma US Inc.
- Class I: Dangerous 12/23/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.